Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Chem ; 33(6): 1656-62, 1990 Jun.
Article in English | MEDLINE | ID: mdl-2342058

ABSTRACT

Nine matched pairs of cephalosporins and their 1-carba-1-dethiacephalosporin analogues have been compared with regard to microbiological activity, beta-lactam carbonyl infrared absorption, and aqueous stability. In general the microbiological activity of the pairs of compounds were very similar across a broad range of bacteria. The infrared absorption bands for the beta-lactam carbonyls of the pairs indicated a general trend for the 1-carba-1-dethiacephalosporins to absorb at lower frequencies than the corresponding cephalosporins. All of the 1-carba-1-dethiacephalosporins did however present a striking stability enhancement over their cephalosporin counterparts at pH = 10 or 11 in water. This marked contrast of MIC similarity with the observed differences in chemical reactivity clearly demonstrates hydroxide ion catalyzed hydrolysis is not a good model for transpeptidase activity unless the compounds comprise a limited domain of structural type.


Subject(s)
Cephalosporins/pharmacology , Cephalosporins/analysis , Cephalosporins/chemical synthesis , Hydrolysis , Microbial Sensitivity Tests , Spectrophotometry, Infrared
2.
J Med Chem ; 21(1): 88-96, 1978 Jan.
Article in English | MEDLINE | ID: mdl-412968

ABSTRACT

Exploration of the effects of "minor" structural differences on the antitumor activity and toxicity of dimeric Catharanthus alkaloids resulted in the preparation of deacetylvinblastine amide (vindesine, VDS) from either vinblastine (VLB) or deacetylvinblastine. Adequate amounts of vindesine for biological testing were prepared by preferential hydrazinolysis of the C23-ester in the vindoline moiety of VLB, followed by hydrogenolysis of the resulting deacetylvinblastine hydrazide. Vindesine in its activity spectrum against rodent tumor systems resembles vincristine (VCR) rather than its parent VLB, while its neurotoxic potential appears to be less than that of VCR. The experimental models developed to estimate this potential include in vitro measurements of axoplasmic transport effects in the cat sciatic nerve and the estimation of neuromuscular disturbances in chickens and monkeys by vindesine in comparison with VCR. A radioimmunoassay for VLB, VCR, and VDS, developed by means of deacetylvinblastine acid azide, has been used to study the pharmacokinetics of vindesine in man. The clinical investigation of vindesine is in progress. Deacetylvinblastine, in contrast to earlier reports, showed activity against several murine tumor systems.


Subject(s)
Vinblastine/analogs & derivatives , Animals , Blood Pressure/drug effects , Cats , Chickens , Haplorhini , Heart Rate/drug effects , Humans , In Vitro Techniques , Kinetics , Lethal Dose 50 , Leukemia, Experimental/drug therapy , Male , Mice , Mice, Inbred Strains , Neoplasms, Experimental/drug therapy , Rats , Respiration/drug effects , Structure-Activity Relationship , Vinblastine/chemical synthesis , Vinblastine/metabolism , Vinblastine/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...